Influence of oscillating positive expiratory pressure and the forced expiratory technique on sputum cell counts and quantity of induced sputum in patients with asthma or chronic obstructive pulmonary disease;Influência da técnica de pressão expiratória positiva oscilante e da técnica de expiração forçada na contagem de células e quantidade do escarro induzido em portadores de asma ou doença pulmonar obstrutiva crônica

Jornal Brasileiro de Pneumologia

Volumn 34, Issue 12, 2008, Pages 1026-1032

  Morsch, Ana Lúcia Bernardo De Carvalho ^a   Amorim, Maria Marta ^b   Barbieri, Andréa ^b   Santoro, Llka Lopes ^b   Fernandes, Ana Luisa Godoy ^b,c  

^a DEPARTMENT OF FOOD ENGINEERING   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Disciplina de Pneumologia   (Brazil)

Author keywords

Asthma; Physical therapy modalities; Pulmonary disease, obstructive chronic; Sputum

Indexed keywords

ADULT; ARTICLE; ASTHMA; CELL COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; KAPLAN MEIER METHOD; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; RANDOMIZED CONTROLLED TRIAL; SPUTUM;

ADULT; ASTHMA; CELL COUNT; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; POSITIVE-PRESSURE RESPIRATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM;

EID: 59349083019     PISSN: 18063713     EISSN: 18063713     Source Type: Journal    
DOI: 10.1590/S1806-37132008001200007     Document Type: Article

References (22)

1. O'byrne PM, Postma DS. The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease. Asthma Research Group. Am J Respir Crit Care Med. 1999;159(5 Pt 2):S41-S63.
2. Brightling CE. Clinical applications of induced sputum. Chest. 2006;129(5):1344-8.
3. McCool FD, Rosen MJ. Nonpharmacologic airway clearance therapies: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):S250-S9.
4. Hasani A, Pavia D, Agnew JE, Clarke SW. Regional lung clearance during cough and forced expiration technique (FET): effects of flow and viscoelasticity. Thorax. 1994;49(6):557-61.
5. National Asthma Education and Prevention Program. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics - 2002. J Allergy Clin Immunol. 2002;110(5 Suppl):S141-219. Erratum in: J Allergy Clin Immunol. 2003;111(3):466.
6. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256-76.
7. Pizzichini E, Pizzichini MM, Hargreave F. Induced sputum in the management of asthma. Semin Respir Crit Care Med. 1998;19(6):581-92.
8. Chung KF. Measurement and assessment of cough and of cough reflex. Eur Respir Rev. 2002;12(85):226-30.
9. Sociedade Brasileira de Pneumologia e Tisiologia. II Consenso Brasileiro sobre Espirometria. J Pneumol. 2002;28(3):S2-S115.
10. de Lima LC, Duarte JB, Lépore Neto FP, Abe PT, Gastaldi AC. Mechanical evaluation of a respiratory device. Med Eng Phys. 2005;27(2):181-7.
11. Volsko TA, DiFiore J, Chatburn RL. Performance comparison of two oscillating positive expiratory pressure devices: Acapella versus Flutter. Respir Care. 2003;48(2):124-30.
12. Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med. 1996;154(2 Pt 1):308-17.
13. Pizzichini E, Pizzichini MM, Efthimiadis A, Hargreave FE, Dolovich J. Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J. 1996;9(6):1174-80.
14. Gondor M, Nixon PA, Mutich R, Rebovich P, Orenstein DM. Comparison of Flutter device and chest physical therapy in the treatment of cystic fibrosis pulmonary exacerbation. Pediatr Pulmonol. 1999;28(4):255-60.
15. Girard JP, Terki N. The Flutter VRP1: a new personal pocket therapeutic device used as an adjunct to drug therapy in the management of bronchial asthma. J Investig Allergol Clin Immunol. 1994;4(1):23-7.
16. Swift GL, Rainer T, Saran R, Campbell IA, Prescott RJ. Use of flutter VRP1 in the management of patients with steroid-dependent asthma. Respiration. 1994;61(3):126-9.
17. Ambrosino N, Callegari G, Galloni C, Brega S, Pinna G. Clinical evaluation of oscillating positive expiratory pressure for enhancing expectoration in diseases other than cystic fibrosis. Monaldi Arch Chest Dis. 1995;50(4):269-75.
18. Leru P, Bistriceanu G, Ibraim E, Stoicescu P. Flutter-VRP1 Desitin - a new physiotherapeutic device for the treatment of chronic obstructive bronchitis. Rom J Intern Med. 1994;32(4):315-20.
19. Bellone A, Lascioli R, Raschi S, Guzzi L, Adone R. Chest physical therapy in patients with acute exacerbation of chronic bronchitis: effectiveness of three methods. Arch Phys Med Rehabil. 2000;81(5):558-60.
20. Pryor JA, Webber BA, Hodson ME, Batten JC. Evaluation of the forced expiration technique as an adjunct to postural drainage in treatment of cystic fibrosis. Br Med J. 1979;2(6187):417-8.
21. App EM, Kieselmann R, Reinhardt D, Lindemann H, Dasgupta B, King M, et al. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: flutter vs autogenic drainage. Chest. 1998;114(1):171-7.
22. Konstan MW, Stern RC, Doershuk CF. Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis. J Pediatr. 1994;124(5 Pt 1):689-93.